Wuxi Zhongde Meilian Biotechnology Co., Ltd., established on 2006-12-05, Business scope includes licensed projects:Production of Class II Medical Devices;Production of Class III Medical Devices;Class III medical device business;Production of formula food for special medical purpose;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Research and development of bio-based materials technology;Manufacturing of bio-based materials;Development of Human Gene Diagnosis and Therapy Technology;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);rental service(Licensed rental services not included);Import and export;Technology Import and Export;Conference and Exhibition Services;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Information Technology Consulting Services;Labor service(Does not include labor dispatch)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

I.M.A. Industria Macchine Automatiche SpA engages in the manufacture and design of automatic machines for the processing and packaging of pharmaceuticals, cosmetics, and tea, coffee, and food products. It operates through following segments: Tea, Food & Other, Pharmaceutical and Tobacco Packaging. The Tea, Food & Other segment involves the production of machines for the packaging of tea and herbal teas in filter bags, coffee in pods for the food and beverage sector, for end-of-line equipment; for the cheese, stock cubes, and tobacco sectors, and for primary packaging of the food sector with the use of flexible material such as horizontal and vertical flow packs, plus related services. The Pharmaceutical segment comprises the machinery for the packaging of capsules and tablets in blisters and bottles; machines for filling bottles and vials with liquid and powdered products in sterile and non-sterile environments; machines for freeze-drying, tube-filling and cartooning and systems for the production of tablets and capsules and for coating and granulation, as well as related services. The Tobacco Packaging segment designs, manufactures and markets machines and plants for tobacco packaging and related services. The company was founded in 1961 and is headquartered in Ozzano dell'Emilia, Italy.

Paul GmbH & Co. KG, a subsidiary of Ruppel GmbH & Co. KG, is a German company located in Steinau an der Strasse. The firm manufactures screening machines. It was founded in 1953 by Hans Paul, Hans Arnold and Werner Seyfert. Peter W. Ruppel and Garvin Ruppel are the current co-CEOs of the firm. Paul GmbH & Co. KG was acquired by Ruppel GmbH & Co. KG on February 16, 2021.

Fenwal, Inc. is a global medical technology company focused on improving transfusion medicine through expertise in blood separation, collection, filtration, storage, and transfusion. It offers apheresis collections, manual collections, therapeutics, specialty products, platelet safety, data management, data management, and customer solutions The company was founded in 1949 and is headquartered in Lake Zurich, IL.

Tianjin Yuanda Filter Co., Ltd., established on 2006-04-24, Business scope includes automotive filters,Auto parts and accessories,Rubber and plastic parts,Various filter materials processing,manufacture,Sales;electronics,Hardware accessories sales;Engage in import and export business permitted by national laws and regulations;Lubricants and chemical products(Dangerous goods and precursor drugs are excluded)Sales;mold design,processing,manufacture;Machinery Parts,Production of machinery and equipment,Sales;paper products,waste paper box,Scrap Steel Purchase and Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Huamei Zhongyuan Biotechnology Co., Ltd., established on 2013-07-25, Business scope includes general items:Biochemical product technology research and development;Engineering and Technology Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products);Medical Research and Experimental Development;Machinery and Equipment Leasing;Cosmetics Retail;Cosmetics Wholesale;Development of Human Gene Diagnosis and Therapy Technology;Sales of Class I Medical Devices;Experimental analysis instrument sales;Drug testing equipment sales;Sales of formula food for special medical purposes;Healthy food(prepackaged)Sales;food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);internet sales(Except for products that require a license for sale);Health Consulting Services(Does not include medical services);Environmental Protection Monitoring.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Inspection and testing service;Forensic identification service;medical service;Labor dispatch service;pharmaceutical production;Production of formula food for special medical purpose.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Daicel Corp. engages in the manufacture and sale of chemical products. It operates through the following segments: Cellulosic Derivatives, Organic Chemicals, Plastics, Pyrotechnic Devices, and Others. The Cellulosic Derivatives segment engages in the production of various cellulosic derivatives such as cellulose acetate, acetate tow for cigarette filters, and water-soluble polymers. The Organic Chemicals segment offers various solvents and fine chemicals; acetic acid, and chiral columns used for separation of optical isomers. The Plastic segment develops unique products for numerous industrial sectors such as engineering plastics, polymer alloys and cyclic-olefin copolymers; and also develops a variety of plastic processed products such as polystyrene sheets, formed trays, and functional films. The Pyrotechnic Devices segment provides motor vehicle safety devices, airbag inflators, aerospace and defense systems. The Others segment includes membrane and warehousing business. The company was founded on September 8, 1919 and is headquartered in Osaka, Japan.

Lydall along with its subsidiaries, design and manufacture specialty engineered filtration media, industrial thermal insulating solutions, automotive thermal and acoustical barriers, medical filtration media and devices, and biopharmaceutical processing components for thermal/acoustical, filtration/separation and bio/medical applications. The Company operates in three segments: Performance Materials, Thermal/Acoustical Metals, and Thermal/Acoustical Fibers. The Performance Materials segment reports the results of the Industrial Filtration, Industrial Thermal Insulation, and Life Sciences Filtration businesses. The Thermal/Acoustical Metals segment reports the results of Lydall’s automotive business, which includes metal parts and related tooling. The Thermal/Acoustical Fibers segment reports the results of Lydall’s automotive business. In February 2014, Lydall Inc acquired industrial filtration businesses (ndrew Filtration) of Andrew Industries Limited (Andrew).

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Shanghai Want Want Food Group Co., Ltd., established on 2001-12-12, Business scope includes entrusted by Want Want Holdings Co., Ltd.,for the companies it invests in:Investment and operation decision,Marketing Services,Fund Operation and Financial Management,Technical support and research and development,information service,Staff training and management;Wholesale of prepackaged food(branch only);software development.(Commodities that do not involve state trade management,Quota involved,of license-managed goods,Apply in accordance with relevant national regulations.) [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Shenzhen Global Greenland New Materials Co., Ltd., established on 2016-06-24, Business scope includes general business items:Research and development of activated carbon and new carbon materials,Sales,Technical Services;Activated carbon mask,Industrial gas masks and canisters,Chemical equipment,Fire Products,water purification equipment,Environmental protection equipment,Air Conditioning and Refrigeration Equipment,Activated carbon equipment and purification regeneration device,Chemical products and raw materials(Free of Hazardous Chemicals,precursor chemicals)promotion of;Environmental control and harmful gas removal program consulting and engineering construction;Environmental Engineering(except construction works);Research and development of materials for blood purification products in the medical industry,Sales and technical consultation;gold extraction material,Catalyst carrier research and development and technical support;Technology development of environmental technologies,technology transfer,technical consulting;Environmental Product Design,R & D and sales;Melt blown cloth,Sales of medical masks;Domestic Trade;Operating import and export business.(above laws,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating),The licensing program is:Insulation project,Mechanical and Electrical Engineering,Anti-corrosion engineering,piping engineering design,R & D and installation;Maintenance of machinery and equipment;Design and Construction of Indoor Hydropower Installation Project;Activated carbon and new carbon materials,Activated carbon mask,Industrial gas masks and canisters,Chemical equipment,Fire Products,water purification equipment,Environmental protection equipment,Air Conditioning and Refrigeration Equipment,Production of activated carbon equipment and purification and regeneration devices,Install;Machine made;Materials for blood purification products in the medical industry,gold extraction material,Production of catalyst supports;Production of melt blown cloth.

The Chemo-Sero Therapeutic Research Institute operates as a pharmaceutical company specializing in the field of biotechnology, immunology, hematology, and microbiology. It develops and manufactures vaccines and blood plasma products. The firm's products include human and veterinary vaccines, diagnostic antigens, and treatments for congenital disorders. They also provides newborn screening tests and quality assurance systems solutions. The company was founded on December 26, 1945 and is headquartered in Kumamoto, Japan.

Shanghai Oufei Filter Co., Ltd., established on 2004-12-16, Business scope includes licensed projects:Production of Class II Medical Devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments) General project:to develop,design,Production of automotive filters(Three filters)and related accessories,daily mask(non-medical)Production,Class II medical device sales,Sales of company-produced products,And provide product after-sales service and technical support.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

The National Institute of Advanced Industrial Science and Technology (AIST), led by President Chubachi, is a public research institution funded by the Japanese government to a large extent. The present AIST is a rather new research organization established in 2001. However, AIST and its predecessor organizations have been contributing to society through continuous advancement in technologies and support to Japanese industries since 1882. Headquarters of AIST are located in Tsukuba and Tokyo. AIST has over 40 autonomous research units in various innovative research fields, and the units are located at ten research bases and several sites (smaller than research bases) of AIST all over Japan. About 2300 researchers (about 2000 with tenure: about 80 from abroad) and a few thousands of visiting scientists, post-doctoral fellows, and students from home and abroad are working at AIST. About 650 permanent administrative personnel and many temporary staff support research works of AIST.

Part of Want Want China Holdings Ltd., I Lan Foods Industrial Co., Ltd. is a Taiwanese company located in Taipei that manufactures rice crackers and distributes confectionaries.

Zhejiang Laien Filtration System Co., Ltd., established on 2019-08-02, The business scope includes purification and filtration devices,Purification filter spare parts,Testing equipment,filter material,Auto Parts and Parts,Motorcycle accessories and parts,Manufacture of mechanical and electrical equipment accessories,processing,Sales;Filtration system technology development,technology transfer,technical consulting,Technical Services;Import and export,Technology Import and Export(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)